CRISPR Journal
Scope & Guideline
Empowering Scientists with Cutting-Edge Discoveries
Introduction
Aims and Scopes
- Genome Editing Techniques and Innovations:
The journal extensively covers novel advancements in CRISPR-based genome editing techniques, including Cas9, Cas12, and base editing, focusing on their mechanisms, efficiency, and applications in various organisms. - Clinical Applications and Therapeutics:
Research on the translation of CRISPR technologies into clinical settings is a significant focus area, including studies on gene therapies for genetic disorders, cancer treatment, and potential applications in regenerative medicine. - Ethics and Policy in Genome Editing:
The journal addresses the ethical implications and regulatory considerations surrounding CRISPR technologies, particularly in the context of human germline editing and the societal impacts of genome editing. - Synthetic Biology and CRISPR Integration:
There is a growing emphasis on the integration of CRISPR with synthetic biology, exploring how these technologies can be used to engineer biological systems for various applications, including agriculture and environmental science. - Off-Target Effects and Safety Assessments:
The journal highlights research addressing the safety and precision of CRISPR editing, including studies on off-target effects, evaluation methodologies, and improvements in targeting accuracy.
Trending and Emerging
- Prime Editing and Next-Generation Editing Technologies:
Prime editing has gained significant attention as a next-generation genome-editing technique, with recent publications exploring its potential advantages over traditional CRISPR methods, including increased precision and reduced off-target effects. - CRISPR in Clinical Trials and Therapeutics:
There is a marked increase in research related to the transition of CRISPR technologies into clinical trials, emphasizing the therapeutic potential of genome editing for treating genetic disorders and cancers. - Artificial Intelligence in CRISPR Research:
The intersection of AI and CRISPR technology is emerging as a vital theme, with papers focusing on how machine learning can enhance CRISPR design, predict outcomes, and optimize editing strategies. - Ethical Considerations of Gene Editing:
With the rapid advancements in CRISPR technology, discussions around the ethical implications of genome editing, particularly in human applications, have become increasingly prominent in the journal. - CRISPR Applications Beyond Gene Editing:
Research exploring CRISPR applications in diagnostics, biosensing, and synthetic biology is on the rise, indicating a shift towards broader uses of CRISPR technologies beyond traditional gene editing.
Declining or Waning
- Basic Mechanistic Studies of CRISPR Systems:
There has been a noticeable decline in publications focusing solely on the basic biological mechanisms of CRISPR systems, as the field shifts towards applied research and clinical applications. - Agricultural Applications of CRISPR:
Although still relevant, the frequency of studies specifically targeting agricultural improvements through CRISPR has diminished, likely due to a growing emphasis on human health applications and clinical research. - Historical and Philosophical Perspectives on CRISPR:
Papers discussing the historical development and philosophical implications of CRISPR technologies have become less common as the journal prioritizes empirical research and immediate applications. - Single-Organism Studies:
Research focusing exclusively on CRISPR applications in single organisms, particularly non-model organisms, has decreased as the community increasingly values studies with broader implications across multiple species. - Regulatory Frameworks for Non-Human Editing:
The focus on regulatory considerations for non-human CRISPR applications, such as in environmental or agricultural contexts, has waned, possibly overshadowed by the urgency of human health applications.
Similar Journals
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
Leading the Charge in Open Access Biotechnology ResearchBIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT is a leading open access journal published by TAYLOR & FRANCIS LTD from the United Kingdom, dedicated to advancing the field of biotechnology since its inception in 1990. Committed to disseminating high-quality research, the journal has transitioned to open access since 2014, enhancing its accessibility for researchers, professionals, and students alike. With a notable impact in the field, it is categorized in the Q3 quartile for Biotechnology as of 2023 and ranks #193 out of 311 in the Scopus categories for Biochemistry, Genetics, and Molecular Biology. The journal aims to cover a diverse range of topics related to both biotechnological advancements and the equipment that supports them, thus fostering innovative research and practical applications in the biotechnology sector. With an evolving scope that reflects the dynamic nature of biological research, BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT plays a crucial role in bridging the gap between laboratory studies and real-world applications, making it an essential resource for anyone involved in biotechnology research.
Cell Stem Cell
Exploring Breakthroughs that Shape the Future of Regenerative MedicineCell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.
GENETICS AND MOLECULAR BIOLOGY
Transforming research into impactful discoveries.GENETICS AND MOLECULAR BIOLOGY, published by the SOC BRASIL GENETICA, is a prominent journal dedicated to the advancement of knowledge in the fields of genetics and molecular biology. Since its inception in 1998, this Open Access journal has served as a vital platform for researchers, professionals, and students to disseminate their findings and engage with the latest innovations and discoveries. With an impact factor that reflects its growing influence, GENETICS AND MOLECULAR BIOLOGY ranks in the Q3 category for both genetics and molecular biology as of 2023, indicating its position within the academic community. The journal is indexed in Scopus, highlighting its commitment to maintaining rigorous peer-review standards while providing wide-reaching access to quality research. Operating out of Ribeirão Preto, Brazil, it fosters a collaborative environment for academic discourse and research development not only in Brazil but also globally. The journal encourages submissions that explore a wide range of topics in genetics and molecular biology, making it an essential resource for anyone involved in these dynamic fields.
Molecular Cell
Connecting Molecular Genetics with Cellular Functionality.Molecular Cell, published by Cell Press, is a leading journal in the fields of cell biology and molecular biology. Established in 1997, this prestigious journal boasts a significant impact within the scientific community, evidenced by its impressive 2023 Scopus rankings, placing it in the top 2% of its field (Rank #10/410 in Molecular Biology, Rank #12/285 in Cell Biology). With a focus on cutting-edge research that bridges the gap between molecular genetics and cellular function, Molecular Cell serves as an essential platform for the dissemination of vital findings and innovative methodologies. Although it follows a traditional publishing model without Open Access options, its rigorous peer-review process and high standards ensure that articles published within these pages are of the utmost quality, making it an invaluable resource for researchers, professionals, and students alike seeking to stay at the forefront of scientific discovery. The journal's address is 50 Hampshire St, Floor 5, Cambridge, MA 02139, United States, reinforcing its commitment to fostering scientific excellence and collaboration.
Cells
Pioneering Discoveries in Biochemistry and GeneticsCells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.
NUCLEIC ACIDS RESEARCH
Exploring the Frontiers of Genetic DiscoveryNUCLEIC ACIDS RESEARCH, published by Oxford University Press, is a premier peer-reviewed journal in the field of genetics, holding a prestigious Q1 ranking in this domain as of 2023. Since its inception in 1974 and with a converged publication horizon extending to 2024, this journal has established itself as a vital resource for researchers and professionals interested in the molecular aspects of nucleic acids, encompassing DNA and RNA studies as well as their implications in biochemistry and molecular biology. With an impressive Scopus rank of #6 out of 347 in Genetics, this journal is positioned in the 98th percentile among its peers, highlighting its significant impact and relevance in the scientific community. As an open access journal since 2005, NUCLEIC ACIDS RESEARCH ensures wide dissemination of knowledge, promoting collaborative advancements in genetic research. For those looking to stay at the forefront of nucleic acid research, this journal remains an essential publication for accessing cutting-edge findings and innovative methodologies in the field.
Frontiers in Genome Editing
Pioneering the Future of Genetic InnovationFrontiers in Genome Editing, published by FRONTIERS MEDIA SA, stands at the forefront of genomic research, specializing in the rapidly evolving realm of gene editing technologies. With an enthusiastic commitment to open access since 2020, this journal facilitates unrestricted distribution of cutting-edge research, making significant advancements in biotechnology and genetics accessible to a global audience. Located in Lausanne, Switzerland, Frontiers in Genome Editing publishes high-quality, peer-reviewed articles that contribute to the understanding and application of genome editing tools, such as CRISPR and TALEN, in various biological fields. Notably, as of 2023, the journal holds a prestigious Q1 ranking in Biotechnology and a Q2 ranking in Genetics, underscoring its importance and influence within these disciplines. With robust Scopus rankings, including a notable percentile placement, Frontiers in Genome Editing is an invaluable resource for researchers, professionals, and students dedicated to the promising future of genomic innovation.
Nature Plants
Advancing Plant Science for a Sustainable FutureNature Plants is a premier journal dedicated to the dynamic and interdisciplinary field of plant science, published by NATURE PORTFOLIO in the United Kingdom. With an impressive impact factor placing it in the top tier of scholarly journals—ranking Q1 in Plant Science for 2023—this journal sets a high standard for research dissemination. Nature Plants has maintained a remarkable Scopus Rank of 5 out of 516 in the Agricultural and Biological Sciences category, reflecting its pivotal role in advancing knowledge in the field. The journal aims to provide a platform for groundbreaking research that addresses key challenges in plant biology, ecology, and agriculture, thereby fostering a deeper understanding of plant science's contribution to global sustainability. Although primarily non-open access, it offers exclusive insights and robust discussions, making it an indispensable resource for researchers, professionals, and students eager to explore the latest advancements and innovations in plant science.
aBIOTECH
Advancing biotechnology for a sustainable future.aBIOTECH, published by SPRINGERNATURE, is a premier academic journal dedicated to advancing the fields of biotechnology, agronomy, and molecular biology. With an impressive ISSN of 2096-6326 and E-ISSN 2662-1738, this journal has established itself as a vital resource for researchers and professionals aiming to publish high-quality, impactful studies. Based in Singapore, aBIOTECH has achieved remarkable recognition, boasting a Q1 ranking in multiple categories including Agronomy and Crop Science, Biochemistry, and Genetics in the 2023 Scopus rankings. Its solid position in the 90th percentile for Biochemistry and Genetics reinforces its significance within the global scientific community. The journal covers a broad spectrum of topics relevant to both basic and applied research, facilitating a shared dialogue amongst scientists and encouraging collaborative progress in innovative biotechnological applications. The open-access nature of the journal ensures that cutting-edge research is freely available, fostering a global exchange of ideas that is critical to the advancement of science today.
BMB Reports
Unlocking Knowledge for a Healthier TomorrowBMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.